Antisoma to present at Needham & Company Sixth Annual Biotechnology
Conference on 13 June 2007
8 June 2007, London, UK - Antisoma plc (LSE: ASM; USOTC: ATSMY) today
announces that its Chief Executive Officer, Glyn Edwards, will be
presenting at the Needham & Company Sixth Annual Biotechnology and
Medical Technology Conference in New York, USA.
Mr Edwards's presentation is scheduled for 11am EST on Wednesday,
June 13, followed by a 30 minute breakout session. A webcast of the
presentation will be available to all on Antisoma's website at
www.antisoma.com.
It is recommended that viewers log on 15 minutes early in order to
register and download any necessary software.
Enquiries:
Katherine Harrison +44 (0)20 8799 8200
Communications Manager
Antisoma plc
Background on Antisoma
Based in London, UK, Antisoma is a biopharmaceutical company that
develops novel products for the treatment of cancer. Antisoma fills
its development pipeline by acquiring promising new product
candidates from internationally recognised academic or cancer
research institutions. Its core activity is the preclinical and
clinical development of these drug candidates. Please visit
www.antisoma.com for further information.
---END OF MESSAGE---